Not logged in Share Save
Share Save
Multiple Myeloma, Version 5.2026 Kumar, Shaji K.; Callander, Natalie S.; Adekola, Kehinde; Anderson, Larry D.; Baljevic, Muhamed; Baz, Rachid; Campagnaro, Erica; Costello, Caitlin; D'angelo, Christopher; Derman, Benjamin; Devarakonda, Srinivas; Elsedawy, Noura; Godara, Amandeep; Godby, Kelly; Hillengass, Jens; Holmberg, Leona; Htut, Myo; Huff, Carol Ann; Hultcrantz, Malin; Kang, Yubin; Larson, Sarah; Lee, Hans C.; Liedtke, Michaela; Martin, Thomas; Omel, James; Robinson, Timothy J.; Rosenberg, Aaron; Sarosiek, Shayna R.; Schroeder, Mark A.; Sherbenou, Daniel; Suvannasankha, Attaya; Valent, Jason; Varshavsky-Yanovsky, Asya Nina; Vogl, Dan; Ye, Jing Christine; Kovach, Emily; Kumar, Rashmi Share Save
Share Save
Share Save
Share Save
NCCN Guidelines® Insights: Multiple Myeloma, Version 1.2025 Kumar, Shaji K.; Callander, Natalie S.; Adekola, Kehinde; Anderson Jr, Larry D.; Baljevic, Muhamed; Baz, Rachid; Campagnaro, Erica; Costello, Caitlin; D'Angelo, Christopher; Derman, Benjamin; Devarakonda, Srinivas; Elsedawy, Noura; Godara, Amandeep; Godby, Kelly; Hillengass, Jens; Holmberg, Leona; Htut, Myo; Huff, Carol Ann; Hultcrantz, Malin; Kang, Yubin; Larson, Sarah; Lee, Hans C.; Liedtke, Michaela; Martin, Thomas; Omel, James; Robinson, Timothy; Rosenberg, Aaron; Schroeder, Mark A.; Sherbenou, Daniel; Suvannasankha, Attaya; Valent, Jason; Varshavsky-Yanovsky, Asya Nina; Vogl, Dan; Kovach, Emily; Kumar, Rashmi Share Save
Share Save
Clonal Hematopoiesis is Associated With Severe Cytokine Release Syndrome in Patients Treated With Chimeric Antigen Receptor T-Cell (CART) Therapy Goldsmith, Scott R.; Shouse, Geoffrey; Wong, F. Lennie; Bosworth, Alysia; Iukuridze, Aleksi; Chen, Sitong; Rhee, June-Wha; Mei, Matthew; Htut, Myo; Janakiram, Murali; Forman, Stephen J.; Pillai, Raju; Budde, L. Elizabeth; Armenian, Saro H. Share Save
Waldenstro m Macroglobulinemia/ Lymphoplasmacytic Lymphoma, Version 2.2024 Kumar, Shaji K.; Callander, Natalie S.; Adekola, Kehinde; Anderson, Larry D.; Baljevic, Muhamed; Campagnaro, Erica; Baz, Rachid; Castillo, Jorge J.; Costello, Caitlin; 'Angelo, Christopher; Derman, Benjamin; Devarakonda, Srinivas; Elsedawy, Noura; Garfall, Alfred; Godby, Kelly; Hillengass, Jens; Holmberg, Leona; Htut, Myo; Huff, Carol Ann; Hultcrantz, Malin; Kang, Yubin; Larson, Sarah; Lee, Hans; Liedtke, Michaela; Martin, Thomas; Omel, James; Robinson, Timothy; Rosenberg, Aaron; Sborov, Douglas; Schroeder, Mark A.; Sherbenou, Daniel; Suvannasankha, Attaya; Valent, Jason; Varshavsky-Yanovsky, Asya Nina; Snedeker, Jenna; Kumar, Rashmi Share Save
Bendamustine vs. fludarabine/cyclophosphamide lymphodepletion prior to BCMA CAR-T cell therapy in multiple myeloma Sidana, Surbhi; Hosoya, Hitomi; Jensen, Alexandria; Liu, Lawrence; Goyal, Anmol; Hovanky, Vanna; Sahaf, Bita; Bharadwaj, Sushma; Latchford, Theresa; Arai, Sally; Leahy, Sheryl; Mei, Matthew; Budde, Lihua E.; Muffly, Lori S.; Frank, Matthew J.; Dahiya, Saurabh; Htut, Myo; Miklos, David; Janakiram, Murali Share Save
Bendamustine lymphodepletion is a well-tolerated alternative to fludarabine and cyclophosphamide lymphodepletion for axicabtagene ciloleucel therapy for aggressive B-cell lymphoma Ong, Shin Yeu; Pak, Stacy; Mei, Matthew; Wang, Yan; Popplewell, Leslie; Baird, John H.; Herrera, Alex F.; Shouse, Geoffrey; Nikolaenko, Liana; Zain, Jasmine; Godfrey, James; Htut, Myo; Aribi, Ahmed; Spielberger, Ricardo; Mansour, Joshua; Forman, Stephen J.; Palmer, Joycelynne; Budde, Lihua E. Share Save
Ethical Challenges with Multiple Myeloma BCMA Chimeric Antigen Receptor T Cell Slot Allocation: A Multi-Institution Experience Kourelis, Taxiarchis; Bansal, Radhika; Berdeja, Jesus; Siegel, David; Patel, Krina; Mailankody, Sham; Htut, Myo; Shah, Nina; Wong, Sandy W.; Sidana, Surbhi; Cowan, Andrew J.; Alsina, Melissa; Cohen, Adam; Holstein, Sarah A.; Bergsagel, Leif; Ailawadhi, Sikander; Raje, Noopur; Dhakal, Binod; Rossi, Adriana; Lin, Yi Share Save
Allogeneic BCMA-targeting CAR T cells in relapsed/refractory multiple myeloma: phase 1 UNIVERSAL trial interim results Mailankody, Sham; Matous, Jeffrey V.; Chhabra, Saurabh; Liedtke, Michaela; Sidana, Surbhi; Oluwole, Olalekan O.; Malik, Shahbaz; Nath, Rajneesh; Anwer, Faiz; Cruz, Jose Carlos; Htut, Myo; Karski, Erin E.; Lovelace, Wade; Dillon, Myles; Butz, Eric; Ying, Wendy; Balakumaran, Arun; Kumar, Shaji K. Share Save
Health-related quality of life in patients given ciltacabtagene autoleucel for relapsed or refractory multiple myeloma (CARTITUDE-1): a phase 1b-2, open-label study Martin, Thomas; Lin, Yi; Agha, Mounzer; Cohen, Adam D.; Htut, Myo; Stewart, A. Keith; Hari, Parameswaran; Berdeja, Jesus G.; Usmani, Saad Z.; Yeh, Tzu-Min; Olyslager, Yunsi; Goldberg, Jenna D.; Schecter, Jordan M.; Madduri, Deepu; Jackson, Carolyn C.; Deraedt, William; Gries, Katharine S.; Fastenau, John M.; Trudeau, Jeremiah J.; Akram, Muhammad; Pacaud, Lida; Jakubowiak, Andrzej; Jagannath, Sundar Share Save
Multiple Myeloma, Version 3.2022 Featured Updates to the NCCN Guidelines Callander, Natalie S.; Baljevic, Muhamed; Adekola, Kehinde; Anderson, Larry D.; Campagnaro, Erica; Castillo, Jorge J.; Costello, Caitlin; Devarakonda, Srinivas; Elsedawy, Noura; Faiman, Matthew; Garfall, Alfred; Godby, Kelly; Hillengass, Jens; Holmberg, Leona; Htut, Myo; Huff, Carol Ann; Hultcrantz, Malin; Kang, Yubin; Larson, Sarah; Liedtke, Michaela; Martin, Thomas; Omel, James; Sborov, Douglas; Shain, Kenneth; Stockerl-Goldstein, Keith; Weber, Donna; Berardi, Ryan A.; Kumar, Rashmi; Kumar, Shaji K. Share Save
A phase 1b dose-escalation/expansion study of BET inhibitor RO6870810 in patients with advanced multiple myeloma Ramasamy, Karthik; Nooka, Ajay; Quach, Hang; Htut, Myo; Popat, Rakesh; Liedtke, Michaela; Tuchman, Sascha A.; Laubach, Jacob; Gasparetto, Cristina; Chanan-Khan, Asher; Hertzberg, Mark; deMario, Mark; Nueesch, Eveline; Chesne, Evelyne; Franjkovic, Izolda; Lechner, Katharina; Kornacker, Martin; Cho, Hearn Jay Share Save
Ciltacabtagene autoleucel, a B-cell maturation antigendirected chimeric antigen receptor T-cell therapy in patients with relapsed or refractory multiple myeloma (CARTITUDE-1): a phase 1b/2 open-label study Berdeja, Jesus G.; Madduri, Deepu; Usmani, Saad Z.; Jakubowiak, Andrzej; Agha, Mounzer; Cohen, Adam D.; Stewart, A. Keith; Hari, Parameswaran; Htut, Myo; Lesokhin, Alexander; Deol, Abhinav; Munshi, Nikhil C.; O'Donnell, Elizabeth; Avigan, David; Singh, Indrajeet; Zudaire, Enrique; Yeh, Tzu-Min; Allred, Alicia J.; Olyslager, Yunsi; Banerjee, Arnob; Jackson, Carolyn C.; Goldberg, Jenna D.; Schecter, Jordan M.; Deraedt, William; Zhuang, Sen Hong; Infante, Jeffrey; Geng, Dong; Wu, Xiaoling; Carrasco-Alfonso, Marlene J.; Akram, Muhammad; Hossain, Farah; Rizvi, Syed; Fan, Frank; Lin, Yi; Martin, Thomas; Jagannath, Sundar Share Save
Multiple Myeloma, Version 3.2021 Kumar, Shaji K.; Callander, Natalie S.; Adekola, Kehinde; Anderson, Larry; Baljevic, Muhamed; Campagnaro, Erica; Castillo, Jorge J.; Chandler, Jason C.; Costello, Caitlin; Efebera, Yvonne; Faiman, Matthew; Garfall, Alfred; Godby, Kelly; Hillengass, Jens; Holmberg, Leona; Htut, Myo; Huff, Carol Ann; Kang, Yubin; Hultcrantz, Malin; Larson, Sarah; Liedtke, Michaela; Martin, Thomas; Omel, James; Shain, Kenneth; Sborov, Douglas; Stockerl-Goldstein, Keith; Weber, Donna; Keller, Jennifer; Kumar, Rashmi Share Save
Share Save
.png){kind=icon}
.png){kind=icon}
Not logged in.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
